CRSP logo

CRSP

CRISPR Therapeutics AG

$51.83
-$1.22(-2.30%)
48
Overall
--
Value
58
Tech
39
Quality
Market Cap
$4.99B
Volume
1.59M
52W Range
$30.04 - $71.13
Target Price
$80.83
Order:

Income Statement

MetricTrendChart
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$5.2M$41.0M$3.1M$289.6M$719.0K$915.0M$1.2M$371.2M$37.3M
Total Revenue
$5.2M$41.0M$3.1M$289.6M$719.0K$915.0M$436.0K$371.2M$37.3M
COST OF GOODS SOLD
Cost of Revenue
----------$101.2M$110.3M$130.3M--
GROSS PROFIT
Gross Profit
$5.2M$41.0M$3.1M$289.6M$719.0K$811.9M$-109.8M$371.2M$37.3M
OPERATING EXPENSES
Operating Expenses
$-73.3M$-105.6M$-162.1M$242.8M$355.2M$541.4M$563.3M$593.7M$503.9M
Research & Development
$42.2M$69.8M$113.8M$179.4M$266.9M$340.6M$461.6M$387.3M$320.7M
Research Expense
$42.2M$69.8M$113.8M$179.4M$266.9M$340.6M$461.6M$387.3M$320.7M
Selling, General & Administrative
$31.1M$35.8M$48.3M$63.5M$88.2M$99.7M$102.5M$76.2M$73.0M
General & Administrative Expenses
$31.1M$35.8M$48.3M$63.5M$88.2M$99.7M$102.5M$76.2M$73.0M
Salaries & Wages
$-10.8M$-20.6M$-39.3M------$97.9M$81.0M$86.6M
Depreciation & Amortization
$-900.0K$-3.0M$-3.5M$4.7M$9.1M$17.9M$24.1M$19.8M$19.2M
Depreciation & Amortization
$-900.0K$-3.0M$-3.5M$4.7M$9.1M$17.9M$24.1M$19.8M$19.2M
Other Operating Expenses
$-73.3M$-105.6M$-162.1M$-2.8M$-7.0M$-101.2M$-10.4M$-9.7M$-5.8M
OPERATING INCOME
Operating income
$-68.1M$-64.6M$-158.9M$46.7M$-354.4M$373.5M$-673.2M$-222.5M$-466.6M
EBITDA
$-21.8M$-63.6M$-160.9M$72.0M$-345.3M$391.5M$-626.3M$-130.9M$-343.4M
NON-OPERATING ITEMS
Intinc
$-8.1M------------$76.4M$104.3M
Net Non-Operating Interest Income/Expense
$-8.1M------------$76.4M$104.3M
Other Income/Expense
$-53.5M$2.0M$5.5M$-20.6M$-6.4M$-6.0M$22.7M$-71.8M$-103.9M
Other Special Charges
$90.0M$-197.0K$-1.2M$26.0M$6.4M$6.0M$22.7M$71.8M$103.9M
PRE-TAX INCOME
EBIT
$-22.7M$-66.6M$-164.4M$67.3M$-354.4M$373.5M$-650.5M$-150.7M$-362.7M
Pre-Tax Income
$-22.7M$-66.6M$-164.4M$67.3M$-348.1M$379.5M$-650.5M$-150.7M$-362.7M
INCOME TAX
Tax Provision
$484.0K$1.7M$553.0K$448.0K$809.0K$1.9M$-325.0K$2.9M$3.6M
NET INCOME
Net Income
$-23.2M$-68.4M$-165.0M$66.9M$-348.9M$377.7M$-650.2M$-153.6M$-366.3M
Net Income (Continuing Operations)
$-23.2M$-68.4M$-165.0M$66.9M$-348.9M$377.7M$-650.2M$-153.6M$-366.3M
Net Income (Discontinued Operations)
$-23.2M$-68.4M$-165.0M$66.9M$-348.9M$377.7M$-650.2M$-153.6M$-366.3M
Net Income (Common Stockholders)
$-23.2M$-68.4M$-165.0M$66.9M$-348.9M$377.7M$-650.2M$-153.6M$-366.3M
Normalized Income
----------------$-359.0M
TOTALS
Total Expenses
$-73.3M$-105.6M$-162.1M$242.8M$355.2M$541.4M$673.6M$593.7M$503.9M
SHARE & EPS DATA
Average Shares Outstanding
$12.3M$40.1M$48.0M$54.4M$65.9M$75.9M$77.7M$79.2M$84.4M
Average Shares Outstanding (Diluted)
$35.0M$41.6M$48.0M$56.9M$65.9M$80.4M$77.7M$79.2M$84.4M
Shares Outstanding
$39.8M$47.0M$52.3M$60.8M$75.4M$77.1M$78.6M$80.3M$85.8M
Basic EPS
$0.43--$-3.44$1.23$-5.29$4.97$-8.36$-1.94$-4.34
Basic EPS (Continuing Operations)
------$1.23$-5.29$4.97$-8.36$-1.94$-4.34
Diluted EPS
$-1.89$-1.71$-3.44$1.17$-5.29$4.7$-8.36$-1.94$-4.34
Diluted EPS (Continuing Operations)
------$1.17$-5.29$4.7$-8.36$-1.94$-4.34
OTHER METRICS
Earnings from equity interest
$-36.5M$-1.8M$-4.3M$-5.5M----------
Earnings From Equity Interest Net Of Tax
$-36.5M$-1.8M$-4.3M$-5.5M----------
Minority Interests
$25.0K----------------
Other Gand A
$31.1M$35.8M$48.3M$63.5M$88.2M$99.7M$102.5M$76.2M$73.0M
Rent And Landing Fees
$31.1M$35.8M$48.3M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CRSP$51.83-2.3%1.59M
3
4
5
6

Get CRISPR Therapeutics AG Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.